Cargando…
Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
BACKGROUND: Several studies stablished a relationship between metabolic disturbances and Alzheimer´s disease (AD) where inflammation plays a pivotal role. However, mechanisms involved still remain unclear. In the present study, we aimed to evaluate central and peripheral effects of dexibuprofen (DXI...
Autores principales: | Ettcheto, Miren, Sánchez-Lopez, Elena, Cano, Amanda, Carrasco, Marina, Herrera, Katherine, Manzine, Patricia R., Espinosa-Jimenez, Triana, Busquets, Oriol, Verdaguer, Ester, Olloquequi, Jordi, Auladell, Carme, Folch, Jaume, Camins, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296685/ https://www.ncbi.nlm.nih.gov/pubmed/34294142 http://dx.doi.org/10.1186/s13578-021-00646-w |
Ejemplares similares
-
Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
por: Ettcheto, Miren, et al.
Publicado: (2017) -
JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function
por: Busquets, Oriol, et al.
Publicado: (2022) -
Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2022) -
Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment
por: Busquets, Oriol, et al.
Publicado: (2019) -
The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
por: Folch, Jaume, et al.
Publicado: (2018)